Cardiovascular Risks Associated with Oral Contraceptives

作者: Lothar A. J. Heinemann , Edeltraut Garbe

DOI: 10.1007/978-3-642-86696-8_5

关键词:

摘要: Methods of steroid hormone contraception have been available since the 1960s and are now thought to be used by more than 100 million women worldwide [I]. The overwhelming majority use contraceptives in their oral application. One can estimate that, currently, 93 users combined (OCs).

参考文章(109)
Øjvind Lidegaard, Birgitte Edström, Svend Kreiner, Oral contraceptives and venous thromboembolism: A case-control study Contraception. ,vol. 57, pp. 291- 301 ,(1998) , 10.1016/S0010-7824(98)00033-X
Jick H, Porter Jb, Hunter, Stergachis A, Oral contraceptives and nonfatal vascular disease. Obstetrics & Gynecology. ,vol. 66, pp. 1- 4 ,(1985)
Brian L. Strom, When Should One Perform Pharmacoepidemiology Studies John Wiley & Sons, Ltd. pp. 59- 66 ,(2002) , 10.1002/9780470059876.CH5
Whyte Jc, Oral contraception and thromboembolic disease Canadian Medical Association Journal. ,vol. 99, pp. 131- 131 ,(1968)
L. E. Böttiger, B. Westerholm, ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE Acta Medica Scandinavica. ,vol. 190, pp. 455- 463 ,(2009) , 10.1111/J.0954-6820.1971.TB07459.X
Samuel Shapiro, Meta-analysis/Shmeta-analysis American Journal of Epidemiology. ,vol. 140, pp. 771- 778 ,(1994) , 10.1093/OXFORDJOURNALS.AJE.A117324
LYNN ROSENBERG, CHARLES H. HENNEKENS, BERNARD ROSNER, CHARLENE BELANGER, KENNETH J. ROTHMAN, FRANK E. SPEIZER, ORAL CONTRACEPTIVE USE IN RELATION TO NONFATAL MYOCARDIAL INFARCTION American Journal of Epidemiology. ,vol. 111, pp. 59- 66 ,(1980) , 10.1093/OXFORDJOURNALS.AJE.A112874